17β-Estradiol prevents fatty streak formation in apolipoprotein E- deficient mice

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 11, 1997, Pages 2679-2684

  Elhage, R ^a   Arnal, J F ^a   Pieraggi, M T ^a   Duverger, N ^b   Fievet C ^c   Faye, J C ^a   Bayard, F ^a  

^a INSERM   (France)

^b RPR Gencell   (France)

^c INSTITUT PASTEUR DE LILLE   (France)

Author keywords

Apolipoproteins; Fatty streak formation

Indexed keywords

CHOLESTEROL; ESTRADIOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; ESTRADIOL BLOOD LEVEL; FEMALE; HYPERLIPOPROTEINEMIA TYPE 3; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031456565     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.11.2679     Document Type: Article

References (13)

1. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary disease: a quantitative assessment of the epidemiological evidence. Prev Med. 1991;20:47-63.
2. Posthuma WF, Westendorp RG, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? Br Med J. 1994;308:1268-1269.
3. Lobo RA, Speroff L. International consensus conference on postmenopausal therapy and the cardiovascular system. Fertil Steril. 1994;61:592-595.
4. Barrett-Connor E. Postmenopausal estrogen and heart disease. Atherosclerosis. 1995;118:S7-S10.
5. Hough IL, Zilversmit DB. Effect of 17β-estradiol on aortic cholesterol content and metabolism in cholesterol-fed rabbits. Arteriosclerosis. 1986;6:57.
6. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
7. Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and combined estrogen-progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest. 1991;87:1274-1279.
8. Wagner JD, Clarkson TB, St Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991;88:1995-2002.
9. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci U S A. 1992;89:11259-11263.
10. Keaney JF, Shwaery GT, Xu AM, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA. 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation. 1994;89:2251-2259.
11. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM. Cardiovascular mortality and noncontraceptive estrogen use in women: results from the Lipid Research Clinic's Program Follow-up Study. Circulation. 1987;75:1102-1109.
12. Plump AS, Smith JD, Hayek T, Aalto-Setälä K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 1992;71:343-353.
13. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468-471.